Vanda Pharmaceuticals Inc. (VNDA) Q4 2025 Earnings Call Transcript
…
65,250€
-0,38%
Echtzeit-Aktienkurs ANI Pharmaceuticals
Bid:
Ask:
Nachrichten zur ANI Pharmaceuticals Aktie
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?
ANI Pharmaceuticals rare disease growth, led by surging Cortrophin Gel sales, is outpacing Tevas slower sales momentum in this head-to-head…
Vanda Pharmaceuticals Inc. (VNDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
…
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
WILMINGTON, Del., Jan. 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today…
ANI Pharmaceuticals überzeugt mit einem starken Umsatzausblick für das Jahr 2026 — Aktie vor Ende der Konsolidierung!
Im Biotechnologie-Bereich gibt es aktuell einige spannende Aktien, die mit schönem Momentum überzeugen. Eine Aktie, die vor einer neuen Aufwärtswelle…
ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?
ANI Pharmaceuticals shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight…
Ionis Pharmaceuticals Aktienanalyse: Milliardenmarkt im Blick - RBC Capital erkennt den nächsten Wachstumsschub
Bad Marienberg (www.aktiencheck.de)???????? Ionis Pharmaceuticals hebt ab: RBC Capital sieht neues Kursziel 95 USD und enormes MarktpotenzialIonis Pharmaceuticals Inc. (ISIN:…
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…
ANIP vs. AMRX: Which Niche Drugmaker Is the Better Pick?
ANI Pharmaceuticals rare-disease momentum, led by surging Cortrophin Gel sales, sets up a stronger growth profile than its diversified rival.…
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals,” the “Company”), a…
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.…
Did ANI Pharmaceuticals (ANIP) Upgraded 2025 Outlook Just Shift Its Investment Narrative?
ANI Pharmaceuticals recently raised its full-year 2025 earnings guidance, now expecting net revenue of US$854 million to US$873 million, up…
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
MIAMI, Oct. 20, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. ("HOPE"), an interventional psychiatry network owned by NRx…
Ionis Pharmaceuticals Aktie: Positive Phase-3-Daten beflügeln Analystenmeinung - Upgrade!
New York (www.aktiencheck.de) - Ionis Pharmaceuticals-Aktienanalyse von Goldman Sachs:Salveen Richter von Goldman Sachs stuft die Aktie von Ionis Pharmaceuticals Inc.…